Paper Review Records
全部论文审稿周期
12 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
115
天
Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer's dementia
作者
Koushi Higashi; Tomohiro Sasaki; Hikari Takahashi; Yosuke Kawai; Stefanie Hennig; Koichi Shimizu; Masami Nakai; Kaneyoshi Takahashi; Yu Nakamura展开收起
作者单位
Office of Clinical Pharmacology, Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., 3-2-27 Otedori, Chuo-ku, Osaka, 540-0021, Japan; Office of Clinical Pharmacology, Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan; Certara Inc., Melbourne, VIC, Australia; Currently QuanTx Consulting, Mountain View, CA, USA; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd., 3-2-27 Otedori, Chuo-ku, Osaka, 540-0021, Japan; Department of Neuropsychiatry, Faculty of Medicine, Kagawa University, Kagawa, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan展开收起
119
天
Characterization of unusual pyrazole ring-rearranged metabolites of DS-1971a specific to monkeys
作者
Daigo Asano; Kazuyoshi Michiba; Kayoko Masuda; Takashi Ohnuki; Makoto Suzuki; Tetsuya Suzuki; Hideyuki Shiozawa; Tsuyoshi Shinozuka; Toshio Takatsu; Daisuke Nakai展开收起
作者单位
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories II, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Discovery Science and Technology Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan; Analytical & Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Corporate Planning Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Center for Pharmaceutical and Biomedical Analysis, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan展开收起
93
天
Development of a method for vancomycin monitoring in interstitial fluid using a novel porous microneedle array patch
作者
Jo Terauchi; Taisei Kawamura; Jongho Park; Kiyomi Saito; Masataka Tajima; Hitoshi Sato; Beomjoon Kim; Erika Sugiyama展开收起
作者单位
Department of Pharmacokinetics and Pharmacodynamics, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan; Department of Precision Engineering, School of Engineering, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8656, Japan; Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-8505, Japan; Innovation Center for Cannabinoid Research, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand展开收起
63
天
Development and validation of LC–MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider
作者
Yuchen Sun; Kosuke Saito; Shin-ichiro Nitta; Ryoya Goda; Yuki Kishino; Hisashi Fujita; Masaaki Kakehi; Yoshiharu Hayashi; Satoshi Ito; Tomomi Ishida; Kiyomi Kikuchi; Kazuko Inoue; Kazutaka Shimbo; Takeru Yamaguchi; Fumihiro Jinno; Kaori Murakoshi; Chie Murata; Kentaro Takahara; Mitsuhiko Kawabata; Ruri Kikura-Hanajiri; Yoshiro Saito展开收起
作者单位
Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan; Mediford Corporation, 1-15-10 Shimura, Itabashi-ku, Tokyo, 174-0056, Japan; Future Peak Co., Ltd., 3-48 Imainakamachi, Nakahara-ku, Kawasaki City, Kanagawa, 211-0065, Japan; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan; Takeda Pharmaceutical Co., Ltd., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; CMIC Pharma Science Co., Ltd., 17-18 Nakahatacho, Nishiwaki City, Hyogo, 677-0032, Japan; Sekisui Medical Co., Ltd., 2117 Muramatsu, Tokai-mura naka-gun, Ibaraki, 319-1182, Japan; Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan; Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa, 210-8681, Japan; Sumika Chemical Analysis Service, Ltd., 3-1-135 Kasugadenaka, Konohana-ku, Osaka City, Osaka, 554-0022, Japan; Axcelead Drug Discovery Partners, Inc., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-0012, Japan; Tanabe Pharma Corporation, 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamotocho, Mishima-gun, Osaka, 618-8585, Japan; Thermo Fisher Scientific K.K., 3-9 Moriyacho, Kanagawa-ku, Yokohama City, Kanagawa, 221-0022, Japan; Shin Nippon Biomedical Laboratories Ltd., 16-1 Minamiakasaka, Kainan-city, Wakayama, 642-0017, Japan; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan展开收起
168
天
125
天
Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma
作者
Ayaka Kojima; Masayuki Nadai; Hiroshi Yamazaki; Miki Katoh展开收起
作者单位
Laboratory of Pharmaceutics, Faculty of Pharmacy, Meijo University, Nagoya, Japan; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Japan展开收起
FAQ
Drug Metabolism and Pharmacokinetics审稿要多久?
截至2026-11-19,CrushSCI 收录了 Drug Metabolism and Pharmacokinetics 的 12 篇完整审稿记录。最快一篇从收稿到录用用了 44 天(K2-EDTA anticoagulant suppresses calcium-dependent paraoxonase 1-mediated hydrolysis in human plasma stability assays,2026-03-06 收稿,2026-04-19 录用),最慢一篇用了 186 天;平均 111 天,中位数 110 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
